"Buy low and sell high." ~ Wall Street adage
President elect Trump's comments about drug prices being too high at today's press conference has caused biotech and pharma stock prices to drop significantly. Some stocks are at or near their 52 week low.
Although risky, I think that some it may be worth buying some biotechs that are significantly beat down. It may be worth selecting about 10 different biotech stocks into which to put new or additional funds. And then selling out when the inevitable near term rebound occurs.
For more on The Practice of Personal Finance, check back Wednesdays for a new segment.
This is not financial advice. Please consult a professional advisor.
Copyright © 2017 Achievement Catalyst, LLC
No comments:
Post a Comment
Comment guidelines: My Wealth Builder will publish comments that are about the topic and do not contain inappropriate language. My Wealth Builder reserves the right to edit or delete comments for any reason which includes those that have advertising (either for a product, website, or blog), contain inappropriate language or are not about the topic.